JIANGSU BAJU PHAEMACEUTICAL CO.,LTD
         
 
        Chemical products (DL-naproxen, acyclovir and its intermediates guanine, solanesol, folic acid, ganciclovir, famciclovir, valacyclovir hydrochloride, gemcitabine, fluvastatin, imatinib, Atazanavir, tenofovir, disoproxil, montelukast, florfenicol, naproxen, clopidogrel, carisoprodol, tert-butyldimethylsilyl chloride and intermediate tert-chlorosilane Butane) production; chemical products (triammonium (2,4,5-triamino 6-hydroxypyrimidine sulfate), diacetylguanine (2,9-diacetylguanine), acyclovir side chain ( 1,4-diacetoxy-2-oxetane), diacetylacyclovir (9-(2-acetoxyethoxymethyl)acetylguanine), etherate (2-methoxy naphthol), acylate (1-(6-methoxy-2-naphthyl)acetone), PTT (phenyltrimethylammonium tribromide), bromide (2-bromo-1-(6-methoxy base-2-naphthyl)propan-1-one)) sales; self-operated and agency import and export business of various commodities and technologies (except for commodities and technologies that are restricted by the state or prohibited from import and export). (Projects that require approval according to law can only be carried out with the approval of relevant departments)
      
  Business Type Manufacturer
 Location ChinaJiangsuChangzhou
 Year Established 2003-12-12
 Total Employees 480
 Total Annual Revenue -
 Main Products 1,2-Epoxybutane, 2-butanone, 2-butanone, hydrochloric acid, 2-methoxynaphthalene, 4-methoxyphenylhydrazine hydrochloride, 6-hydroxypurine, butyl, amino, butyl Alkane, tris(hydroxymethyl)aminomethane, kojic acid dipalmitate, blue copper peptide, acetone, acetone, hydrochloric acid, sulfuric acid, propionic acid, imatinib, tert-butyldimethylsilyl chloride, folic acid, Purine, p-hydroxybenzoic acid, industrial naphthalene, isoprene, pentadiene, n-butane, chlorosilane, methylchlorosilane, dipotassium glycyrrhizate, biphenyl dianhydride, methylchlorosilane, hydrochloric acid, hydrochloric acid, Sulfuric acid, silane glycol dimethyl ester, sulfur, sulfuric acid, pure benzene, benzoic acid, benzoate, benzoate, guanine, ketone, ester, acyclovir
 Main Market -